• SENSEX 72,472.33
    879.09 (+1.23%)
  • BANKNIFTY 55,256.65
    741.60 (+1.36%)
  • Adani Ports
    1,769.75 1,891.80(%)
  • GMR Airports
    92.17 115.60(%)
  • Anthem Bioscienc
    833.00 579.45(%)
  • Reliance Industries
    1,160.40 1,160.40(%)
  • Moneyview
    63.50 64.61(%)
  • Cupid
    368.05 368.05(%)
  • Life Insurance
    394.50 468.30(%)
  • TCS
    2,204.00 3,336.70(%)
  • NSE
    1,737.40 1,878.00(%)
  • Kotak Mah. Bank
    445.20 452.98(%)
  • Oil India
    441.95 395.75(%)
  • Kanohar Elect.
    1,095.35 672.05(%)
  • Hexaware Tech.
    574.45 808.40(%)
  • HDFC Bank
    709.90 1,020.35(%)
  • Tour. Fin. Corp.
    150.15 154.40(%)
  • Acme India
    232.05 232.05(%)
  • Colgate-Palmoliv
    1,867.45 2,329.85(%)
  • Swiggy
    232.30 232.30(%)
  • Max Healthcare
    915.00 1,221.10(%)
  • Petronet LNG
    295.30 326.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Unjha Formulations Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 7112.0
  • ISIN : INE576D01015
33.90 1 (3.99%)
  • As on 09 Oct 2026 (EOD)

  • Today’s Low

    31.00

  • Today’s High

    33.90

  • Open

    32.60

  • Perv Close

    32.60

  • 52W Low

    17.52

  • 52W High

    36.38

Key Indicators

  • P/E(TTM)

    32.29

  • Mar.Cap (₹Cr.)

    15.19

  • Div & Yield %

    0.00

  • Book Value(₹)

    8.58

  • Debt-Equity Ratio

    3.99

  • AGM Date

    09-Oct-2026

  • EPS

    1.05

  • P/E Ratio

    32.29

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    15.19

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.48

  • BV (₹)

    8.60

  • Sales( ₹ in Cr.)

    15.59

  • NP (in Cr.)

    0.70

  • NP Var(%)

    74.0

  • Div%

    0.0

  • CPS (₹)

    1.90

  • EPS (₹)

    1.60

  • Traded Value (₹ in Lakhs)

    15.19

  • 52 Week High

    36.38

  • 52 Week Low

    17.52

  • Price BSE

    34.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    15.19

  • P/C Ratio

    18.00

  • P/E Ratio

    21.60

  • Price Vs.BV

    1.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 15.59 13.86 18.50 13.15 14.16 9.96
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 15.59 13.86 18.50 13.15 14.16 9.96
Other Income 0.16 0.11 0.01 0.03 0.19 0.22
Stock Adjustments -0.16 -0.27 0.22 -0.08 0.24 0.12
Total Income 15.59 13.70 18.73 13.10 14.59 10.30
EXPENDITURE :            
Raw Materials 11.88 11.15 15.78 10.61 11.70 7.67
Power and Fuel Cost 0.07 0.06 0.07 0.06 0.06 0.06
Employee Cost 0.94 0.81 0.78 0.51 0.56 0.48
Other Manufacturing Expenses 0.25 0.32 0.89 0.76 1.12 0.92
Selling and Administration Expenses 1.33 0.73 0.63 0.69 0.56 0.72
Miscellaneous Expenses 0.01 0.00 0.00 0.00 0.07 0.08
Employee Benefit Expenses 0.94 0.81 0.78 0.51 0.56 0.48
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 14.49 13.07 18.15 12.64 14.08 9.93
Operating Profit 1.11 0.63 0.58 0.47 0.51 0.35
Interest 0.01 0.01 0.05 0.06 0.13 0.17
Gross Profit 1.10 0.62 0.53 0.41 0.38 0.18
Depreciation 0.14 0.10 0.08 0.08 0.08 0.08
Profit Before Tax 0.96 0.52 0.45 0.33 0.30 0.10
Current Tax 0.26 0.12 0.17 0.05 0.05 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.01 0.00 0.01 0.00 0.00 0.00
Reported Net Profit 0.70 0.41 0.28 0.28 0.25 0.10
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.70 0.41 0.28 0.28 0.25 0.10
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -2.76 -2.86
P & L Balance brought forward -1.54 -1.94 -2.22 -2.50 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -0.83 -1.54 -1.94 -2.22 -2.50 -2.76
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.57 0.91 0.62 0.63 0.56 0.23
Earnings Per Share(Adj)-Unit Curr 1.57 0.91 0.62 0.63 0.56 0.23
Book Value 8.58 7.01 6.10 5.48 4.84 4.28
Book Value(Adj)-Unit Curr 8.58 7.01 6.10 5.48 4.84 4.28

Shareholding Pattern

  • Promoter Group

    36.93%

  • Public Share Holding

    63.08%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,654,424 36.93 1,654,424 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,654,424 36.93 1,654,424 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 41,965 0.94 38,665 17
Clearing Members 1,067 0.02 0 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 19,751 0.44 16,551 26
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 277,362 6.19 0 48
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 548,150 12.23 548,150 13
Individuals holding nominal share capital up to Rs. 1 lakh 1,937,518 43.24 1,432,318 4,109
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,826,076 63.08 2,035,684 4,219
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 4,480,500 100.00 3,690,108 4,223

Company Background

Unjha Formulations LtdPharmaceuticals - Indian - Formulations

  • Unjha Formulations Ltd
  • BSE Code : 7112.0
  • ISIN : INE576D01015

  • Incorporation Year

    1994

  • Registered Office

    Khali Char Rasta
    State Highway Ta Sidhpur, Patan,
    Gujarat-384151

  • Telephone

    91-2767-282395

  • FAX

    91-2767-282396

  • Chairman

    Jashodaben S Patel

  • Managing Director

    Krutiben M Patel

  • Company Secretary

    Khushboo N Patel

  • Auditor

    Jain & Golechha

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Unjha Formulations Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Unjha Formul. 33.90 15.75 15.59 32.29 20.53
Abbott India 25,999.85 7,217.19 6,929.05 34.22 43.78
Astrazeneca Phar 5,831.85 2,304.07 2,275.58 85.95 27.86
Glaxosmi. Pharma 2,539.80 3,932.76 3,790.20 40.57 58.17
Novartis India 2,047.55 393.10 354.33 51.71 15.94
Cipla 1,303.30 20,102.60 18,979.95 34.25 13.88
Bliss GVS Pharma 644.55 773.53 729.81 59.90 12.51
Fermenta Biotec. 517.50 474.15 450.25 24.16 18.77
Amrutanjan Healt 508.30 520.13 502.55 27.23 24.16
Guj. Themis Bio. 363.25 168.25 165.82 97.13 18.05
Ambalal Sarabhai 40.29 19.52 3.94 74.61 6.77